Teva Pharmaceutical Industries Limited (FRA:TEV)

FRA:TEV Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,281	24,154	10,588	9,478	7,769	8,646
Market Cap Growth	-4.71%	128.13%	11.71%	22.00%	-10.15%	-9.34%
Enterprise Value	28,608	39,874	27,443	28,328	28,089	29,300
Last Close Price	13.15	21.40	9.16	8.56	7.42	7.89
PE Ratio	-	-	-	-	21.19	-
PS Ratio	1.08	1.51	0.74	0.68	0.56	0.64
PB Ratio	2.63	4.37	1.44	1.18	0.79	0.96
P/FCF Ratio	20.16	33.39	13.90	9.72	37.44	16.58
P/OCF Ratio	12.91	20.05	8.56	6.37	11.07	8.70
EV/Sales Ratio	1.99	2.50	1.91	2.03	2.01	2.15
EV/EBITDA Ratio	7.07	9.32	7.00	7.63	7.25	7.77
EV/EBIT Ratio	9.43	12.24	9.54	11.37	10.38	11.73
EV/FCF Ratio	37.75	55.12	36.03	29.06	135.36	56.18
Debt / Equity Ratio	2.56	3.18	2.50	2.52	2.10	2.40
Debt / EBITDA Ratio	3.58	3.98	4.53	5.26	5.19	5.57
Debt / FCF Ratio	19.69	24.28	24.08	20.80	99.97	41.59
Asset Turnover	0.41	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.26	2.41	2.09	2.08	2.02	2.02
Quick Ratio	0.48	0.50	0.54	0.57	0.61	0.51
Current Ratio	1.06	0.98	1.02	1.05	1.14	0.99
Return on Equity (ROE)	-2.42%	-28.30%	-7.36%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	5.71%	5.09%	4.54%	3.63%	3.91%	3.53%
Return on Capital (ROIC)	9.34%	8.06%	6.78%	5.11%	5.31%	4.77%
Return on Capital Employed (ROCE)	13.20%	12.70%	10.20%	8.20%	8.40%	8.20%
Earnings Yield	-0.87%	-6.55%	-4.78%	-24.15%	4.72%	-37.73%
FCF Yield	4.96%	3.00%	7.20%	10.29%	2.67%	6.03%
Buyback Yield / Dilution	-1.25%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Shareholder Return	-	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.